NCT02410369 - Study of S-588410 After Adjuvant Chemotherapy for Completely Resected Non-small- Cell Lung Cancer | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 31, 2015

Primary Completion Date

March 31, 2020

Study Completion Date

September 30, 2021

Conditions

Non-small- Cell Lung Cancer

Interventions

DRUG

S-588410

Following randomization, subjects with HLA-A\*2402 in the investigational arm will receive the subcutaneous administration of S-588410.

DRUG

Placebo

Following randomization, subjects with HLA-A\*2402 in the investigational arm will receive the subcutaneous administration of Placebo.

Trial Locations (1)

RECRUITING

Institute of Medical Science, The University of Tokyo, Tokyo